公开(公告)号：US20200345666A1

公开(公告)日：2020-11-05

申请号：US16957410

申请日：2018-12-20

申请人： NUBEBE CO., LTD. ,  HUMAN HERB CO., LTD.

发明人： Young Woo LIM ,  Ji Myeong OK ,  Woon Ho LEE ,  Young Bin KIM

IPC分类号： A61K31/137 ,  A61K36/884 ,  A61K36/346 ,  A61K36/488 ,  A61K36/882 ,  A61K36/49 ,  A61K36/8994 ,  A61K36/31 ,  A61K36/736 ,  A61K36/8945 ,  A61K36/185 ,  A61K47/02 ,  A61K47/46 ,  A61K36/534 ,  A61K36/744 ,  A61K36/538 ,  A61K36/708 ,  A61K33/04 ,  A61K36/64 ,  A61K36/65 ,  A61K9/19 ,  A61K36/258 ,  A61K36/481 ,  A61K36/284 ,  A61K36/54 ,  A61K36/9068 ,  A61K36/076 ,  A61K36/752 ,  A61K36/725 ,  A61K36/734 ,  A61K36/575 ,  A61P3/04

摘要： An embodiment of the present invention provides an herbal medicinal tablet formulation for treating obesity which can be prescribed based on Sasang constitutional medicine, including:an ephedra powder agent of which ephedrine content is concentrated to be 3.0 to 4.0%, which is greater than 0.5 to 2.5% when it is in a natural state, and of which the ephedrine content is maintained constant at 3.0 to 4.0%; and a side-effect-preventing powder agent for each constitution prescribed based on Sasang constitutional medicine in order to prevent a side effect of the ephedra powder agent, wherein a weight ratio of the ephedra powder agent and the side-effect-preventing powder agent is 8-10:1 to 9-11:1.

公开(公告)号：US20210069064A1

公开(公告)日：2021-03-11

申请号：US16957432

申请日：2018-12-20

申请人： NUBEBE CO., LTD. ,  HUMAN HERB CO., LTD.

发明人： Young Woo LIM ,  Ji Myeong OK ,  Woon Ho LEE ,  Young Bin KIM

IPC分类号： A61J3/06 ,  A61K36/17 ,  A61K36/62 ,  A61K9/28

摘要： An embodiment of the present invention provides a manufacturing method of an herbal medicinal tablet formulation for treating obesity which can be prescribed based on Sasang constitutional medicine, comprises manufacturing a concentrated and quantified ephedra powder agent so that an ephedrine content of ephedra, which differs from 0.5-2.5% depending on a producing district and collecting period, is 3.0-4.0%, determining a weight according to each constitution of Sasang constitutional medicine of the concentrated and quantified ephedra powder agent of which the ephedrine content is 3.0-4.0%, and manufacturing a side-effect-preventing powder agent for each constitution to prevent and suppress side effects according to constitution of Sasang constitutional medicine with respect to the weight of the ephedra powder agent, preparing the ephedra powder agent and the side-effect-preventing powder agent while varying a weight ratio therebetween in consideration of weight, obesity, constitution of Sasang constitutional medicine, and side effects while mixing the ephedra powder agent and the side-effect-preventing powder agent; tableting a mixture of the prepared ephedra powder agent and side-effect-preventing powder agent; coating the tableted ones after tableting; and after the coating, while sorting out defective ones from coated ones and packaging, displaying a label including information prepared according to weight, obesity, constitution of Sasang constitutional medicine, and side effects.

公开(公告)号：US11484514B2

公开(公告)日：2022-11-01

申请号：US16957432

申请日：2018-12-20

申请人： NUBEBE CO., LTD. ,  HUMAN HERB CO., LTD.

发明人： Young Woo Lim ,  Ji Myeong Ok ,  Woon Ho Lee ,  Young Bin Kim

IPC分类号： A61P3/04 ,  A61K36/346 ,  A61K36/488 ,  A61K36/882 ,  A61K36/49 ,  A61K36/8994 ,  A61K36/31 ,  A61K36/736 ,  A61K36/8945 ,  A61K36/185 ,  A61K47/02 ,  A61K47/46 ,  A61K36/534 ,  A61K36/744 ,  A61K36/538 ,  A61K36/708 ,  A61K33/04 ,  A61K36/64 ,  A61K36/65 ,  A61K31/137 ,  A61K9/19 ,  A61K36/258 ,  A61K36/481 ,  A61K36/284 ,  A61K36/54 ,  A61K36/9068 ,  A61K36/076 ,  A61K36/752 ,  A61K36/725 ,  A61K36/734 ,  A61K36/575 ,  A61K36/884 ,  A61J3/06 ,  A61K9/28 ,  A61K36/17 ,  A61K36/62

摘要： An embodiment of the present invention provides a manufacturing method of an herbal medicinal tablet formulation for treating obesity which is prescribed based on Sasang constitutional medicine, comprises manufacturing a concentrated ephedra powder agent so that an ephedrine content is 3.0-4.0%; determining a weight of the concentrated ephedra powder agent according to each constitution of Sasang constitutional medicine, and manufacturing a side effect-preventing powder agent for each constitution to prevent and suppress side effects according to constitution of Sasang constitutional medicine with respect to the weight of the concentrated ephedra powder agent; mixing the concentrated ephedra powder agent and the side effect-preventing powder agent with a variance of a weight ratio therebetween in consideration of weight, obesity, constitution of Sasang constitutional medicine, and side effects; and tableting the mixture of the prepared ephedra powder agent and side effect-preventing powder agent.